James Engelhart
Chief Financial Officer, Biohaven Pharmaceutical Holding Co Ltd.
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Strategic Advisor Jan 7, 2022 to Oct 3, 20221
- Biohaven Pharmaceutical Holding Co Ltd.Chief financial officer May 3, 2017 to Dec 10, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Biohaven Pharmaceutical Holding Co Ltd.0 shares3Oct 3, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 3, 2022Returned to company 15,900 shares at $148.50 of Biohaven Pharmaceutical Holding Co Ltd.3
- Jan 7, 2022Shares withheld for tax 1,279 shares at $128.87 of Biohaven Pharmaceutical Holding Co Ltd.4
- Jan 7, 2022Exercised options 3,250 shares of Biohaven Pharmaceutical Holding Co Ltd.4
- Jan 6, 2022Shares withheld for tax 1,532 shares at $123.86 of Biohaven Pharmaceutical Holding Co Ltd.4
- Jan 6, 2022Exercised options 3,750 shares of Biohaven Pharmaceutical Holding Co Ltd.4
- Dec 10, 2021Sold 1,382 shares at $103.85 of Biohaven Pharmaceutical Holding Co Ltd.5
- Dec 10, 2021Sold 23,487 shares at $102.70 of Biohaven Pharmaceutical Holding Co Ltd.5
- Dec 10, 2021Sold 10,131 shares at $102.01 of Biohaven Pharmaceutical Holding Co Ltd.5
- Dec 10, 2021Exercised options 35,000 shares of Biohaven Pharmaceutical Holding Co Ltd.5
- Nov 25, 2021Shares withheld for tax 1,715 shares at $115.55 of Biohaven Pharmaceutical Holding Co Ltd.6
- Nov 25, 2021Exercised options 3,700 shares of Biohaven Pharmaceutical Holding Co Ltd.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 7, 2022
- 5SEC EDGARForm 4 filed Dec 10, 2021
- 6SEC EDGARForm 4 filed Nov 26, 2021